ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that its Annual Meeting of Stockholders will be webcast live on June 20, 2013 and can be accessed by visiting the investor relations section of the Company’s website at: http://www.ariad.com/investor.
The annual meeting will take place at 10:00 a.m. (EDT) at the Company’s offices in Cambridge, Massachusetts and will include an overview of ARIAD and its key programs provided by Harvey J. Berger, M.D., chairman and chief executive officer of ARIAD, and key members of senior management. A replay will be available on the investor page of the ARIAD website approximately three hours after the presentation and will be archived for four weeks. To ensure a timely connection to the live webcast, participants should log on at least five minutes prior to the scheduled start time.
ARIAD Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts and Lausanne, Switzerland, is an integrated global oncology company focused on transforming the lives of cancer patients with breakthrough medicines. ARIAD is working on new medicines to advance the treatment of various forms of chronic and acute leukemia, lung cancer and other difficult-to-treat cancers. ARIAD utilizes computational and structural approaches to design small-molecule drugs that overcome resistance to existing cancer medicines. For additional information, visit http://www.ariad.com or follow ARIAD on Twitter ( @ARIADPharm).